Michelle Cortes-Salva

Title: Michelle Cortes-Salva: Innovator in Stroke Treatment

Introduction

Michelle Cortes-Salva is a prominent inventor based in Fairfax Station, Virginia. She has made significant contributions to the field of stroke treatment through her innovative research and patented methods. Her work focuses on the development of novel sigma agonists that have the potential to improve recovery outcomes for stroke patients.

Latest Patents

Cortes-Salva holds a patent for her invention titled "N,N'-di-1 naphthylguanidine HCl (NAGH) and N,N'-di-p-nitrophenylguanidine HCl (NAD) treatment for stroke at delayed timepoints." This patent presents a method of treating stroke by administering a novel sigma agonist. The research demonstrated that systemic administration of NAGH and NAD, when given 24 hours after a stroke, significantly reduced neural damage and enhanced behavioral recovery. The findings suggest that these compounds could extend the therapeutic window for stroke treatment beyond current options.

Career Highlights

Cortes-Salva is affiliated with the University of South Florida, where she continues her research in neuroprotection and stroke recovery. Her innovative approach has garnered attention in the scientific community, and her work is paving the way for new treatment strategies.

Collaborations

Cortes-Salva has collaborated with notable colleagues, including Keith R. Pennypacker and Alison Elizabeth Willing. These partnerships have contributed to the advancement of her research and the exploration of new therapeutic avenues.

Conclusion

Michelle Cortes-Salva is a trailblazer in the field of stroke treatment, with her patented methods showing promise for improving patient outcomes. Her dedication to research and innovation continues to inspire advancements in medical science.